PATRICIA S POLING MD NPI 1528010899

NPI Details

Patricia S Poling, MD is an internal medicine in Naples, FL with 31 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Patricia S Poling, MD NPI is 1528010899. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS
Graduation Year:1995

The provider's business location address is:

400 8TH ST N
NAPLES, FL
ZIP 34102-519
Phone: (239) 430-5547
Fax: (239) 430-5544

The NPI 1528010899 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Vitamin d-3 level (HCPCS:82306)
• Hemoglobin a1c level (HCPCS:83036)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Automated urinalysis test (HCPCS:81003)
• Bacterial colony count, urine (HCPCS:87086)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Urine microalbumin (protein) level (HCPCS:82043)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Red blood count, manual test (HCPCS:85044)
• Cervical or vaginal cancer screening; pelvic and clinical breast examination (HCPCS:G0101)
• Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory (HCPCS:Q0091)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Thyroid hormone, t3 measurement, total (HCPCS:84480)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Magnesium level (HCPCS:83735)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Uric acid level, blood (HCPCS:84550)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report (HCPCS:G0403)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Bacterial urine culture (HCPCS:87088)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Folic acid level, serum (HCPCS:82746)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)

The enumeration date for this NPI number is 5/16/2006 and was last updated on 6/14/2009.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.